Jim Cramer Looks At Blackstone, Praises MercadoLibre: 'They're Incredibly Smart'
Portfolio Pulse from Avi Kapoor
Jim Cramer discussed several companies on CNBC's 'Mad Money Lightning Round,' highlighting potential in Freeport-McMoRan with a new CEO, praising AbbVie's Parkinson's treatment in Canada, commending MercadoLibre's intelligence and financial results, and suggesting Blackstone over Oxford Lane Capital for credit expertise. He noted Freeport-McMoRan's limited upside, AbbVie's strength, MercadoLibre's smart management, and uncertainties around Oxford Lane Capital.
February 09, 2024 | 1:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Oxford Lane Capital's uncertain credit expertise and asset knowledge contrast with Cramer's preference for Blackstone's proven capabilities.
Cramer's skepticism about Oxford Lane Capital's credit expertise and preference for Blackstone could negatively impact OXLC's perception.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
AbbVie's advanced Parkinson's disease treatment availability in Canada and Cramer's positive outlook may support its stock.
The availability of AbbVie's Parkinson's treatment in Canada and Cramer's endorsement could have a favorable short-term impact.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Jim Cramer's endorsement of Blackstone over Oxford Lane Capital for credit expertise could bolster investor confidence in BX.
Cramer's preference for Blackstone due to its credit expertise may positively influence BX's stock in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 75
POSITIVE IMPACT
Freeport-McMoRan could see a short-term rise with market manipulation by China and the appointment of Kathleen L. Quirk as president and CEO.
The anticipation of market manipulation by China and leadership change could positively impact FCX's stock in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
MercadoLibre's strong Q3 financial results and Cramer's long-term investment and praise suggest positive momentum.
Cramer's long-term support and the company's impressive Q3 financial performance indicate a positive outlook for MELI.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85